Video

MPN Heroes® Recognition Program 2021

Author(s):

CURE Media Group

Watch the entire MPN Heroes® Recognition Program here!

Watch the entire MPN Heroes® Recognition Program here!

CURE® is proud to host the ninth annual MPN Heroes® recognition program, an evening of gratitude and celebration for individuals who go above and beyond in their efforts to support patients with MPNs.

Each MPN Hero is nominated by patients, caregivers, advocates and health care professionals for their heroic contributions in the field of MPN or in the individual lives of those living with the disease.

Related Videos
Dr. Richard “Rick" Winneker
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.
Image of man with grey hair.
Image of bald man in suit.
Image of woman with brown hair.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Related Content
The EC has approved Rytelo in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome: © Crystal_Light - stock.adobe.com.
March 25th 2025

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

Ryan Scott
The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.
Cancer Horizons podcast logo
January 8th 2024

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Illustration of blood cells.
March 3rd 2025

Rusfertide Elicits Promising Responses in Polycythemia Vera

Alex Biese
Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted in positive responses.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
December 16th 2021

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek Darlene Dobkowski, MA
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
Illustration of red blood cells.
January 10th 2025

P1101 Treatment Meets Phase 3 Primary End Point in Essential Thrombocythemia

Ryan Scott
P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the primary end goal of SURPASS-ET.
Image of woman with blondish hair.
December 30th 2024

Empowering Patients With Cancer Through Clear Clinical Trial Communication

Darlene Dobkowski, MA
A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and potential side effects.